Alzinova AB (publ) (STO:ALZ)
0.7310
+0.0050 (0.69%)
Feb 11, 2026, 11:07 AM CET
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 75.74 million as of February 11, 2026. Its market cap has decreased by -73.46% in one year.
Market Cap
75.74M
Enterprise Value
76.05M
Revenue
26.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.73
Market Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 75.74M, an increase of 32.07%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 75.74M | -12.42% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 127.27M |
| Alligator Bioscience AB | 105.89M |
| Annexin Pharmaceuticals AB | 103.77M |
| Biosergen AB | 102.38M |
| Active Biotech AB | 100.70M |
| Spago Nanomedical AB | 85.67M |
| Scandinavian ChemoTech AB | 80.30M |
| OncoZenge AB | 75.00M |